A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes
Individual Clinical
Pharmacokinetics & Abuse Liability
ALL
Chapman (2022)
acute e-cig inhalation impacts vascular health: a study in smoking naïve subjects.
Individual Clinical
Safety
Adverse Effects
Chatterjee (2021)
Short halt in vaping modifies cardiorespiratory parameters and urine metabolome: a randomized trial.
Individual Clinical
Safety
Adverse Effects
Chaumont (2020)
Electronic cigarette vapour moderately stimulates pro-inflammatory signalling pathways and interleukin-6 production by human monocyte-derived dendritic cells.
Individual Clinical
Safety
Adverse Effects
Chen (2020)
Electromembrane extraction of nicotine in inhaled aerosols from tobacco cigarettes, electronic cigarettes, and heated tobacco products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Chen (2022)
Increased Levels of the acrolein Metabolite 3-hydroxypropyl Mercapturic acid in the Urine of e-Cigarette Users.
Individual Clinical
Biomarkers
Biommarkers Of Exposure
Chen (2023)
health risks of dual use of electronic and combustible cigarettes: exposure to acrylamide and glycidamide.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
Increased acrolein-DNa adducts in buccal brushings of e-cigarette users.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
association of Vaping and Respiratory health among Youth in the Population assessment of Tobacco and health (PaTh) Study Wave 3.
Individual Clinical
Respiratory Toxicity
Relative Health Effect Of User
Cherian (2021)